Black Diamond Therapeutics (BDTX) Total Liabilities (2018 - 2021)
Historic Total Liabilities for Black Diamond Therapeutics (BDTX) over the last 4 years, with Q3 2021 value amounting to $55.2 million.
- Black Diamond Therapeutics' Total Liabilities rose 18904.14% to $55.2 million in Q3 2021 from the same period last year, while for Sep 2021 it was $55.2 million, marking a year-over-year increase of 18904.14%. This contributed to the annual value of $21.9 million for FY2020, which is 34910.84% up from last year.
- As of Q3 2021, Black Diamond Therapeutics' Total Liabilities stood at $55.2 million, which was up 18904.14% from $36.9 million recorded in Q2 2021.
- Black Diamond Therapeutics' 5-year Total Liabilities high stood at $55.2 million for Q3 2021, and its period low was $4.9 million during Q4 2019.
- Its 4-year average for Total Liabilities is $23.4 million, with a median of $20.6 million in 2019.
- As far as peak fluctuations go, Black Diamond Therapeutics' Total Liabilities crashed by 7984.0% in 2020, and later skyrocketed by 48279.84% in 2021.
- Black Diamond Therapeutics' Total Liabilities (Quarter) stood at $6.6 million in 2018, then dropped by 26.05% to $4.9 million in 2019, then soared by 349.11% to $21.9 million in 2020, then surged by 151.82% to $55.2 million in 2021.
- Its Total Liabilities stands at $55.2 million for Q3 2021, versus $36.9 million for Q2 2021 and $32.5 million for Q1 2021.